During the last session, AnaptysBio Inc (NASDAQ:ANAB)’s traded shares were 0.65 million, with the beta value of the company hitting -0.24. At the end of the trading day, the stock’s price was $21.00, reflecting an intraday gain of 11.29% or $2.13. The 52-week high for the ANAB share is $27.50, that puts it down -30.95 from that peak though still a striking 36.38% gain since the share price plummeted to a 52-week low of $13.36. The company’s market capitalization is $561.96M, and the average trade volume was 324.15K shares over the past three months.
AnaptysBio Inc (NASDAQ:ANAB) trade information
AnaptysBio Inc (ANAB) registered a 11.29% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 11.29% in intraday trading to $21.00, hitting a weekly high. The stock’s 5-day price performance is 5.69%, and it has moved by -1.78% in 30 days. Based on these gigs, the overall price performance for the year is 0.14%.
AnaptysBio Inc (ANAB) estimates and forecasts
Statistics show that AnaptysBio Inc has underperformed its competitors in share price, compared to the industry in which it operates. AnaptysBio Inc (ANAB) shares have gone up 19.18% during the last six months, with a year-to-date growth rate less than the industry average at -1.48% against 12.90. In the rating firms’ projections, revenue will decrease -2.00% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 3.73M as predicted by 9 analyst(s). Meanwhile, a consensus of 9 analyst(s) estimates revenue growth to 3.97M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 3.57M and 3.46M respectively. In this case, analysts expect current quarter sales to grow by 4.50% and then jump by 14.70% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -19.45%. While earnings are projected to return -2.21% in 2024.
ANAB Dividends
AnaptysBio Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
